These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7831992)

  • 81. Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena.
    Naarding P; Kremer HP; Zitman FG
    Eur Psychiatry; 2001 Dec; 16(8):439-45. PubMed ID: 11777733
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The case for heterogeneity in the etiology of schizophrenia.
    Tsuang MT; Faraone SV
    Schizophr Res; 1995 Oct; 17(2):161-75. PubMed ID: 8562491
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Suffering and suicide in tumor patients].
    Stiefel F
    Schweiz Rundsch Med Prax; 1993 Mar; 82(9):260-2. PubMed ID: 8506449
    [TBL] [Abstract][Full Text] [Related]  

  • 84. An abused psychotic preadolescent at risk for Huntington's disease.
    Sokol MS; Pfeffer CR; Solomon GE; Esman AH; Robinson G; Gold RL; Orr-Andrawes A
    J Am Acad Child Adolesc Psychiatry; 1989 Jul; 28(4):612-7. PubMed ID: 2527841
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dynamic mutations and psychiatric genetics.
    O'Donovan MC; Owen MJ
    Psychol Med; 1996 Jan; 26(1):1-6. PubMed ID: 8643749
    [No Abstract]   [Full Text] [Related]  

  • 86. Family break-down and stress in Huntington's chorea.
    Tyler A; Harper PS; Davies K; Newcome RG
    J Biosoc Sci; 1983 Apr; 15(2):127-38. PubMed ID: 6221016
    [No Abstract]   [Full Text] [Related]  

  • 87. Policy choices available in genetic counseling for people at-risk for Huntington's disease.
    Johnston R; Seitz K
    Psychiatr Q; 1981; 53(3):194-200. PubMed ID: 6458834
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Personality disorder in Huntington's disease.
    Dewhurst K
    Psychiatr Clin (Basel); 1970; 3(4):221-9. PubMed ID: 4248176
    [No Abstract]   [Full Text] [Related]  

  • 89. Cholesterol and mental disorder.
    Boston PF; Dursun SM; Reveley MA
    Br J Psychiatry; 1996 Dec; 169(6):682-9. PubMed ID: 8968624
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Outrageous fortune: the risk of suicide in genetic testing for Huntington disease.
    Bird TD
    Am J Hum Genet; 1999 May; 64(5):1289-92. PubMed ID: 10205259
    [No Abstract]   [Full Text] [Related]  

  • 91. Trends in suicidology: personality as an endophenotype for molecular genetic investigations.
    Savitz JB; Cupido CL; Ramesar RS
    PLoS Med; 2006 May; 3(5):e107. PubMed ID: 16646633
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attempt.
    Jeremian R; Bani-Fatemi A; Strauss JS; Tasmim S; Dada O; Graff-Guerrero A; Gerretsen P; De Luca V
    Schizophr Res; 2022 May; 243():222-224. PubMed ID: 31174921
    [No Abstract]   [Full Text] [Related]  

  • 93. Genetic counseling and the presenile dementias.
    Heston LL
    Soc Biol; 1976 SUMMER; 23(2):135-41. PubMed ID: 138936
    [No Abstract]   [Full Text] [Related]  

  • 94. Behavioural phenotypes and their measurement.
    O'Brien G
    Dev Med Child Neurol; 1992 Apr; 34(4):365-7. PubMed ID: 1572522
    [No Abstract]   [Full Text] [Related]  

  • 95. The pathobiology of depression in Huntington's disease: an unresolved puzzle.
    Jellinger KA
    J Neural Transm (Vienna); 2024 Feb; ():. PubMed ID: 38349403
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington's disease.
    McLauchlan DJ; Linden DEJ; Rosser AE
    Front Neurosci; 2022; 16():993357. PubMed ID: 36643017
    [TBL] [Abstract][Full Text] [Related]  

  • 97. New Avenues for the Treatment of Huntington's Disease.
    Kim A; Lalonde K; Truesdell A; Gomes Welter P; Brocardo PS; Rosenstock TR; Gil-Mohapel J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445070
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Roché MW; Ready RE; Perlmutter JS; Chou KL; Barton SK; McCormack MK; Stout JC; Cella D; Miner JA; Paulsen JS
    Qual Life Res; 2020 Dec; 29(12):3419-3439. PubMed ID: 32813263
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Understanding domains that influence perceived stigma in individuals with Huntington disease.
    Boileau NR; Paulsen JS; Ready RE; Hahn EA; Lai JS; Carlozzi NE
    Rehabil Psychol; 2020 May; 65(2):113-121. PubMed ID: 31961169
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.
    Carlozzi NE; Goodnight S; Kratz AL; Stout JC; McCormack MK; Paulsen JS; Boileau NR; Cella D; Ready RE
    J Huntingtons Dis; 2019; 8(4):467-482. PubMed ID: 31424415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.